Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Date:
01/01/2017
Locations:
Lead Investigators:
Summary
This study is about treatment options for cytomegalovirus infections in people who have received stem cell transplants. The main aim of the study is to check if the cytomegalovirus infection can no longer be detected after treatment with marivabir or valganciclovir.